Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03554811
Other study ID # 2018015
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date December 31, 2023

Study information

Verified date August 2021
Source Fresno Community Hospital and Medical Center
Contact Rachel Dirks, PhD
Phone 559-459-4029
Email rdirks@communitymedical.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Critically ill patients in the intensive care unit are known to lose muscle mass and function at a rapid rate. Currently, there is a global recognition and shift in the ICU culture to reduce sedation and encourage exercise and mobilization early during the ICU stay. Functional stimulation assisted supine cycling can be applied to patients in the bed and does not require patient participation. This study seeks to evaluate the effect of conventional exercise and early mobilization in combination with functional stimulation assisted supine cycling applied early during the ICU on muscle mass, strength, and physical function, as well as patient-reported disability as compared to conventional exercise and early mobilization alone.


Recruitment information / eligibility

Status Recruiting
Enrollment 32
Est. completion date December 31, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - = 18 years of age - Admitted to the ICU with a predicted ICU length of stay = 4 days - Expected to survive the ICU stay - Expected to receive mechanical ventilation > 48 hours - Able to perform physical outcome measures pre-morbidly (with or without an assisted device) Exclusion Criteria: - Proven or suspected neuromuscular weakness affecting the legs (eg- stroke or Guillain-Barré syndrome) - Lower limb amputation(s) - Assessed by medical staff as approaching imminent death or withdrawal of medical treatment within 36 hours - Pregnancy - Body mass index > 40 - Presence of external fixator or superficial metal in lower limb - Open wounds or skin abrasions at electrode application points - Presence of pacemaker or implanted defibrillator - Transferred from another ICU after >48 hours of consecutive mechanical ventilation - Lower limb malignancy - Pre-existing intellectual disability or cognitive impairment limiting the ability to accurately follow instructions - Body habitus unable to fit the bike - Palliative goals of care - Unable to participate in FESC within 48 hours of ICU admission due to logistic reasons or due to failure in daily screening for participation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Functional electrical stimulation assisted supine cycling (FESC)
A supine cycle ergometer attached to a six-channel stimulator will be used for FESC. Surface electrodes will be applied to the hamstrings, quadriceps, and calf muscles on both legs. Muscles will be stimulated at specific stages throughout the cycling phase. Each session will start with a 1 minute motor-driven passive cycling warm-up at a rate of 20 revolutions per minute. Patients will continue with passive, active-assisted, or active cycling, according to their level of participation. If the patients stop cycling actively, the ergometer will revert to passive cycling.
Other:
Conventional early exercise and mobility interventions
These interventions will be based on the patient's alertness and medical stability, and includes activities to maintain or increase limb range of motion and strength, in and out of bed mobility, sit to stand, and transfer training, as well as assisted ambulation.

Locations

Country Name City State
United States Community Regional Medical Center Fresno California

Sponsors (2)

Lead Sponsor Collaborator
Fresno Community Hospital and Medical Center Western University of Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent change of rectus femoris cross-sectional area Ultrasound measurements will be done with patients in supine position with their leg in passive extension and neutral rotation. Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
Secondary Diaphragm muscle thickness Thickness will be measured by ultrasound at the zone of apposition during inspiration or expiration using the intercostal approach. Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
Secondary Muscle strength Muscle strength will be assessed using the Medical Research Council Scale. This muscle scale grades muscle power on a scale of 0 to 5 in relation to the maximum expected for that muscle. Weaker muscles will range from 0-3 and stronger muscles will receive grades 4 or 5. Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge
Secondary Muscle strength Muscle strength will be assessed using hand-held dynamometry Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge
Secondary Physical function Physical function will be assessed using the physical function in ICU (PFIT) test Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
Secondary Physical function Physical function will be assessed using the functional status score in the ICU (FSS-ICU). This score consists of 3 pre-ambulation categories (rolling; supine to sit transfer; and unsupported sitting) and 2 ambulation categories (sit to stand transfers; ambulation). Each category is scored from 1 (total dependent assistance) to 7 (complete independence) with a total score range of 0-35 (0: unable to perform a task due to physical limitations or medical status). Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
Secondary Physical function Physical function will be assessed using the short physical performance battery (SPPB) Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
Secondary Physical function Physical function will be assessed using the six-minute walk test (6MWT) Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
Secondary Quality of life Quality of life will be measured using the 36-item Short Health Survey (SF-36), which assess eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Each item is scored on a 0-100 scale and items in the same category are averaged together to create the 8 scale scores, with 0 being the lowest score and 100 being the highest for each category. At hospital discharge (an average of 15 days after admission), and 90 days, 6 months, and 1 year post ICU discharge
Secondary Cognition Cognition will be assessed using the Montreal Cognitive Assessment (MoCA). At hospital discharge (an average of 15 days after admission)
Secondary Hospital length of stay The total hospital length of stay for this admission will be calculated. Through hospital discharge, an average of 15 days
Secondary ICU length of stay The total ICU length of stay for this admission will be calculated. Through ICU discharge, an average of 11 days
Secondary Duration of mechanical ventilation The total length of time on mechanical ventilation Through discontinuation of mechanical ventilation, an average of 10 days
See also
  Status Clinical Trial Phase
Terminated NCT04430283 - Evaluation of FDY-5301 in Major Trauma Patients in ICU Phase 2
Completed NCT05527678 - 5 Years Quality of Life and Early Mobilization in ICU
Recruiting NCT05537298 - Muscle Recovery After Critical Illness
Completed NCT05473546 - Diarrhea and Stipsis in Critically Ill Patients (NUTRITI)
Not yet recruiting NCT05326633 - Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors Early Phase 1
Not yet recruiting NCT06025760 - Evaluation of Diaphragmatic Function and Quadriceps Muscle Thickness in Patients Receiving High Protein Nutrition N/A
Completed NCT05048953 - The Use of Musculoskeletal Ultrasound for the Detection of ICU-Acquired Weakness
Terminated NCT04095533 - ICU Associated Weakness and Bedside Ultrasound Assessment
Terminated NCT04160039 - Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit N/A
Active, not recruiting NCT04944537 - Current Situation and Analysis of ICU Management for Severe Trauma Patients in China
Recruiting NCT05865314 - Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial) N/A
Completed NCT04810273 - Effect of Progressive Early Mobilization in Patients With TBI N/A
Completed NCT04396197 - Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care
Recruiting NCT04932330 - Risk Factors of ICU-acquired Weakness
Completed NCT05008562 - How COVID-19 Effects to Muscle Mass Change ın ICU?
Recruiting NCT05919940 - Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO ) N/A
Recruiting NCT04565002 - Transcutaneous Electrical Diaphragmatic Stimulation in Critically Ill Elderly Patients N/A
Recruiting NCT05396066 - Respiratory and Quadriceps Muscle Fatigability After an ICU Acquired Weakness
Recruiting NCT04998643 - Muscle Catabolism and Outcomes in Children Following Cardiac Surgery
Not yet recruiting NCT06184945 - Behavioral Economic & Staffing Strategies in the ICU N/A